Shortages of kinds of pharmaceutical drugs, including antibiotic and cancer treatments have become increasingly common in recent year. In fact, more than 150 drugs and therapeutics have been in short supply due to various causes, including manufacturers abandoning low-profit products. When supplies are low, doctors and officials have had to ration the treatments, reports Sheri Fink, often deciding who gets the drugs in arbitrary ways but these critical shortages, and decisions, have largely been kept from the public.
Read more at The New York Times
